In Brief: Gliatech Adcon-L
This article was originally published in The Gray Sheet
Executive Summary
Gliatech Adcon-L: Resorbable barrier gel's premarket approval application will receive expedited review by FDA, the firm says. The PMA was accepted for filing in February. Adcon-L is intended to act as "a barrier to post surgical peridural fibrosis and adhesions following lumbar surgery" ("The Gray Sheet" Aug. 26, 1996, In Brief)...